Synopsis

ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare Company profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's, "Biogen Idec Inc.: Pharmaceuticals and Healthcare Company profile, SWOT & Financial Report" is a crucial resource for industry executives and anyone looking to access key information about Biogen Idec Inc.

ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare Company profile, SWOT & Financial Report" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about "Biogen Idec Inc." for business intelligence requirements.
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
• Provides data on company financial performance.
• The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.

Reasons To Buy

• Quickly enhance your understanding of "Biogen Idec Inc."
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’ businesses better.
• Recognize potential partnerships and suppliers.

Key Highlights

Biogen Idec Inc. (Biogen) is a leading biotechnology company focusing on the development, manufacturing and commercialization of therapies used in the areas of oncology, neurology, immunology and cardiology. It offers products to address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, chronic lymphocytic leukemia and psoriasis. It has a broad pipeline of several products in clinical trials. The company markets four products, namely, AVONEX, RITUXAN, TYSABRI and FUMADERM in more than 90 countries worldwide, principally in Canada, Australia, Japan and Europe. The company also provides informational, emotional, financial, and logistical support services to care givers and patients. Biogen operates 47 subsidiaries. Biogen is headquartered in Cambridge, Massachusetts, US.

Table Of Contents

Table of Contents

1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Net Debt vs. Gearing Ratio
2.2.4 Operational Efficiency
2.2.5 Solvency
2.2.6 Valuation
2.3 Key Competitors
3 Mergers and Acquisitions and Partnerships
3.1 MandA and Partnerships Strategy
4 Recent Developments
5 SWOT Analysis
5.1 SWOT Analysis - Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 Company Statement
7 History
8 Key Employees
9 Key Employee Biographies
10 Locations and subsidiaries
10.1 Head Office
10.2 Other Locations and subsidiaries
11 Appendix
11.1 Methodology
11.2 Ratio Definitions
11.3 Disclaimer




List of Tables

Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: History
Table 5: Key Employees
Table 6: Key Employee Biographies
Table 7: Subsidiaries
Table 8: Locations




List of Figures

Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Operational Efficiency
Figure 5: Solvency
Figure 6: Valuation




Companies Mentioned

Biogen Idec Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Drug and Medication Industry: Prostate Cancer – Pipeline Review, H1 2012

Drug and Medication Industry: Prostate Cancer – Pipeline Review, H1 2012

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

Rhinovirus Infection - Pipeline Review, H1 2014

Rhinovirus Infection - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Rhinovirus Infection - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Rhinovirus Infection - Pipeline Review, H1 2014', provides an overview of the Rhinovirus Infection's therapeutic pipeline. ...

Rhabdomyosarcoma - Pipeline Review, H1 2014

Rhabdomyosarcoma - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Rhabdomyosarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Rhabdomyosarcoma - Pipeline Review, H1 2014', provides an overview of the Rhabdomyosarcoma's therapeutic pipeline. This report ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.